ICO Iconovo AB (publ)

0.1004USD1.020 SEK · STO+2.20%Mkt Cap: 9.66M USDP/E: —

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler…

Key Statistics

Company
Market Cap9.66M USD
Enterprise Value7.40M USD
Revenue (TTM)238.27K USD
Gross Profit1.13M USD
Net Income (TTM)-4.27M USD
Revenue/Share0.0030 USD
Last Price0.1004 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees12
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0010868943
Valuation
P/E (Trailing)—
P/E (Forward)-0.93
PEG—
EV/EBITDA-2.07
EV/Revenue31.07
P/S40.52
P/B0.69
EPS (TTM)-0.05 USD
EPS (Forward)-0.11 USD
52W Range
0.085617% of range0.1713
52W High0.1713 USD
52W Low0.0856 USD
Profitability
Gross Margin1042.65%
Oper. Margin-1529.44%
EBITDA Margin0.00%
Profit Margin-3925.50%
ROE-36.77%
ROA-33.08%
ROIC-37.61%
ROCE-36.17%
Growth
Revenue Growth10000.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.14M USD
CapEx (TTM)1.39M USD
FCF Margin-1164.89%
FCF Yield-28.75%
Net Debt-2.25M USD
Net Debt/EBITDA0.63
Net Debt/FCF—
Balance Sheet
Debt/Equity0.03
Current Ratio2.84
Quick Ratio2.84
Book Value/Sh0.15 USD
Cash/Share0.03 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.0837 USD
Upside (mean)-16.7%
Target Range0.0837 USD – 0.0837 USD
# Analysts1
Ownership
Shares Out.96.17M
Float92.64M
Insiders48.89%
Institutions33.65%
Technical
SMA 500.1127 (-10.9%)
SMA 2000.1127 (-10.9%)
Beta0.43
S&P 52W Chg12.00%
Avg Vol (30d)47.20K
Avg Vol (10d)34.49K
Technical Indicators
RSI (14)42.0
MACD-0.0339
MACD Signal-0.0215
MACD Hist.-0.0124
BB Upper0.1295 USD
BB Middle0.1109 USD
BB Lower0.0923 USD
BB Width33.56%
ATR (14)0.0063 USD
Vol Ratio (20d)0.23x

About Iconovo (STO: ICO)

›

Iconovo (STO: ICO) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 12 employees.

The shares were at 1.020 SEK on 19 November 2026, down 40.5% over 52 weeks. Its 52-week range is 0.8700 SEK to 1.740 SEK: the price is 41.4% below the high and 17.2% above the low.

Its market capitalisation is 98.10M SEK.

Iconovo reports return on equity of -36.8%.

It holds more cash than debt, a net cash position of 22.88M SEK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 0.8500 SEK is 16.7% below the current price.